Metformin or insulin treatment
Phase 2Small molecule
Metformin or insulin treatment is one of 40 small molecule programs targeting Atypical Endometrial Hyperplasia. It is currently in Phase 2.
2
Indications
2
Total Trials
1
Active Trials
39
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
1063 competitors in Pancreatic Cancer
#DrugCompanyPhaseTrials
1Gemzar
GGynecologic Oncology Group
Preclinical
MS Contin
Merck & Co.Preclinical
Metformin or insulin treatment
FFudan University
Phase 2
Alpha-Glucosidase Inhibitors
SanofiPreclinical
Active Comparator
ModernaPreclinical
Chemotherapy Agents
TakedaPreclinical
Meglitinides
SanofiPreclinical
Secretin-Ferring
FerringPreclinical
Concurrent Lenvatinib
TTrans Tasman Radiation Oncology Group
Preclinical
Rybelsus
PfizerPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- FFudan University